Lack of association between serum adiponectin levels and the Pro12Ala polymorphism in Asian Indians
暂无分享,去创建一个
V. Mohan | V. Radha | R. Deepa | K. S. Vimaleswaran | S. Ghosh | S. Babu | M. Anjana | P. P. Majumder | M. R. S. Rao
[1] V. Mohan,et al. Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4). , 2005, Metabolism: clinical and experimental.
[2] S. Grundy,et al. Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. , 2004, The Journal of clinical endocrinology and metabolism.
[3] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[4] M. Marmot,et al. Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in South Asians and Europeans , 1992, Diabetologia.
[5] V. Mohan,et al. Serum immunoreactive insulin responses to a glucose load in Asian Indian and European Type 2 (non-insulin-dependent) diabetic patients and control subjects , 1986, Diabetologia.
[6] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[7] V. Mohan,et al. The Chennai Urban Rural Epidemiology Study (CURES)--study design and methodology (urban component) (CURES-I). , 2003, The Journal of the Association of Physicians of India.
[8] M. Matsuda,et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. , 2003, Diabetes.
[9] M. Stumvoll,et al. CORRESPONDENCE No Influence of the PPAR 2 Pro12Ala Genotype on Serum Adiponectin Concentrations in Healthy Europeans , 2003 .
[10] T. Saruta,et al. PPAR(gamma)2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population. , 2002, Metabolism: clinical and experimental.
[11] Lee-Ming Chuang,et al. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. , 2002, Diabetes care.
[12] N. Cox,et al. Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene. , 2002, The Journal of clinical endocrinology and metabolism.
[13] N. Abate,et al. Ethnicity and type 2 diabetes: focus on Asian Indians. , 2001, Journal of diabetes and its complications.
[14] M. Stumvoll,et al. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity. , 2001, Diabetes.
[15] M. Kasuga,et al. The Pro12 -->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. , 2001, Diabetes.
[16] J. Beilby,et al. A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity. , 2001, European journal of endocrinology.
[17] Eric S. Lander,et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes , 2000, Nature Genetics.
[18] T. Kadowaki,et al. The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 Diabetes , 2000 .
[19] J. Auwerx,et al. Impact of the Peroxisome Proliferator Activated Receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus , 2000, International Journal of Obesity.
[20] S. Grundy,et al. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. , 1999, The Journal of clinical endocrinology and metabolism.
[21] C. Yen,et al. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations. , 1998, Diabetes.
[22] Johan Auwerx,et al. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity , 1998, Nature Genetics.
[23] H. King,et al. Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.
[24] B. Spiegelman. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. , 1998, Diabetes.
[25] J. Levy,et al. Insulin Resistance in Patients of Asian Indian and European Origin with Non-Insulin Dependent Diabetes , 1987, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.